SCHEMBL26164183

SCHEMBL26164183

O=[N+]([O-])c1cccc2c1[nH]c1c(Cl)cccc1c1ccccc1c1ccccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.67
MAPT P10636 3/20 0.54
NPC1 O15118 1/20 0.54
MAPK1 P28482 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
FBP1 P09467 4/20 0.49
TDP1 Q9NUW8 3/20 0.48
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HPGD P15428 2/20 0.45
SIRT2 Q8IXJ6 1/20 0.44
DYRK1A Q13627 1/20 0.43
MAPK10 P53779 1/20 0.42
RIPK1 Q13546 1/20 0.42
PTGES O14684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7242400 0.80 PARP1 (1.00) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL26164139 0.80 PARP1 (0.71) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL26164146 0.78 PARP1 (0.63) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL30455197 0.78 PARP1 (0.68) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL1135541 0.78 PARP1 (0.68) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL26164155 0.77 PARP1 (0.61) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL18933922 0.75 PARP1 (0.45) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL28479193 0.74 PARP1 (0.54) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL30275708 0.73 DNA2 (0.56) PARP1MAPTNPC1MAPK1L3MBTL1
SCHEMBL1017079 0.73 DNA2 (0.56) PARP1MAPTNPC1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP PARP1 2010/4885MAPT 1004/4885NPC1 1538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.